TrademarkDir
EVYLATT
DEAD

Serial Number

88846939

Owner

Levo Therapeutics, Inc.

Attorney

Carissa L. Weiss

Filing Date

Mar 25, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EVYLATT Trademark

Serial Number: 88846939

EVYLATT is a trademark filed by Levo Therapeutics, Inc. on March 25, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Levo Therapeutics, Inc. (17 trademarks)

Skokie, IL 60077

Entity Type: 03

Trademark Details

Filing Date

March 25, 2020

Registration Date

Not Registered

Published for Opposition

July 21, 2020

Goods & Services

Pharmaceutical products and preparations for the treatment of Prader-Willi syndrome (PWS) and related disorders; pharmaceutical products and preparations for the treatment of neurodevelopmental and metabolic disorders

Scientific research and development; research and development in the pharmaceutical and biotechnology fields; development of pharmaceutical preparations and medicines; medical and scientific research for developing and providing programs and questionnaires for disease-specific assessment and care

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 16, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 16, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 9, 2023 EXRA
SOU EXTENSION 5 GRANTED
Mar 8, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 3, 2023 AITU
SOU EXTENSION 5 FILED
Feb 16, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 16, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 28, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 28, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 28, 2022 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2022 EXRA
SOU EXTENSION 4 GRANTED
Aug 17, 2022 EX4G
SOU EXTENSION 4 FILED
Aug 17, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 17, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 18, 2022 EXRA
SOU EXTENSION 3 GRANTED
Feb 16, 2022 EX3G
SOU EXTENSION 3 FILED
Feb 16, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 16, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 31, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 31, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 31, 2022 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 20, 2021 EXRA
SOU EXTENSION 2 GRANTED
Aug 18, 2021 EX2G
SOU EXTENSION 2 FILED
Aug 18, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 18, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 2, 2021 EXRA
SOU EXTENSION 1 GRANTED
Feb 26, 2021 EX1G
SOU EXTENSION 1 FILED
Feb 26, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 26, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 15, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2020 CNSA
ASSIGNED TO EXAMINER
Jun 16, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 30, 2020 NWOS
NEW APPLICATION ENTERED
Mar 28, 2020 NWAP

Related Trademarks

More from this Owner

PRALYBRI CARBETOCIN logo

PRALYBRI CARBETOCIN

PRALYBRI CARBETOCIN logo

PRALYBRI CARBETOCIN

PRALYBRI CARBETOCIN logo

PRALYBRI CARBETOCIN

PRALYBRI CARBETOCIN logo

PRALYBRI CARBETOCIN

LEVO THERAPEUTICS

LEVO THERAPEUTICS

LEVO logo

LEVO